Category EU Centralised Procedure

EC issues notice on the handling of duplicate MAAs of pharmaceutical products under Article 82(1) of Regulation (EC) No 726/2004

The European Commission (EC) has issued a notice on the handling of duplicate marketing authorisation applications (MAAs) of pharmaceutical products under Article 82(1) of Regulation (EC) No 726 Basically, this means duplicate MAAs for products authorised via the centralised procedure.…

Read MoreEC issues notice on the handling of duplicate MAAs of pharmaceutical products under Article 82(1) of Regulation (EC) No 726/2004